ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
13.79
+0.15 (1.14%)
Aug 27, 2025, 12:45 PM - Market open

ImageneBio Statistics

Total Valuation

ImageneBio has a market cap or net worth of $154.14 million. The enterprise value is $171.39 million.

Market Cap154.14M
Enterprise Value 171.39M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

ImageneBio has 11.18 million shares outstanding.

Current Share Class 11.18M
Shares Outstanding 11.18M
Shares Change (YoY) n/a
Shares Change (QoQ) -99.48%
Owned by Insiders (%) 1.42%
Owned by Institutions (%) 11.26%
Float 10.14M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 35.85
Forward PS n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 39.86
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.37

Current Ratio 0.37
Quick Ratio 0.18
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -68.79

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 143.65%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, ImageneBio has paid $13,000 in taxes.

Income Tax 13,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -37.88% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -37.88%
50-Day Moving Average 15.62
200-Day Moving Average 16.61
Relative Strength Index (RSI) 39.97
Average Volume (20 Days) 16,539

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, ImageneBio had revenue of $4.30 million and -$33.91 million in losses. Loss per share was -$0.09.

Revenue4.30M
Gross Profit 4.30M
Operating Income -21.53M
Pretax Income n/a
Net Income -33.91M
EBITDA -21.44M
EBIT -21.53M
Loss Per Share -$0.09
Full Income Statement

Balance Sheet

The company has $6.02 million in cash and $23.27 million in debt, giving a net cash position of -$17.25 million or -$1.54 per share.

Cash & Cash Equivalents 6.02M
Total Debt 23.27M
Net Cash -17.25M
Net Cash Per Share -$1.54
Equity (Book Value) -15.11M
Book Value Per Share -0.43
Working Capital -21.53M
Full Balance Sheet

Cash Flow

Operating Cash Flow -25.31M
Capital Expenditures n/a
Free Cash Flow -25.31M
FCF Per Share -$2.26
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -500.72%
Pretax Margin -503.35%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ImageneBio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -22.00%
FCF Yield -16.42%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

ImageneBio has an Altman Z-Score of -19.3 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -19.3
Piotroski F-Score 1